Advances in the pharmacological study of cerase—A new anti-tuberculous agent

Abstract

Although several enzymes have previously been tried therapeutically, cerase is the first to show definite antibacterial effect. Low toxicity and highly specific antibacterial activity facilitate clinical research, and the apparent anti-tuberculous activity in both animal and human cases justifies larger scale clinical trials, which are in progress. Besides bibliographical data, this article contains information about the pharmacological properties of cerase, and preliminary observations on its use in the treatment of human tuberculosis.